SE8901241L - Peptide derivatives - Google Patents

Peptide derivatives

Info

Publication number
SE8901241L
SE8901241L SE8901241A SE8901241A SE8901241L SE 8901241 L SE8901241 L SE 8901241L SE 8901241 A SE8901241 A SE 8901241A SE 8901241 A SE8901241 A SE 8901241A SE 8901241 L SE8901241 L SE 8901241L
Authority
SE
Sweden
Prior art keywords
sugar residue
omega
amino group
attached
peptide
Prior art date
Application number
SE8901241A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8901241D0 (sv
Inventor
R Albert
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8901241D0 publication Critical patent/SE8901241D0/xx
Publication of SE8901241L publication Critical patent/SE8901241L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8901241A 1988-04-08 1989-04-07 Peptide derivatives SE8901241L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (2)

Publication Number Publication Date
SE8901241D0 SE8901241D0 (sv) 1989-04-07
SE8901241L true SE8901241L (sv) 1990-02-02

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901241A SE8901241L (sv) 1988-04-08 1989-04-07 Peptide derivatives

Country Status (19)

Country Link
US (1) US5541159A (instruction)
JP (2) JPH01305099A (instruction)
AT (1) ATA900689A (instruction)
AU (2) AU3362889A (instruction)
BE (1) BE1004357A4 (instruction)
CH (1) CH682152A5 (instruction)
DK (1) DK163689A (instruction)
ES (1) ES2015645A6 (instruction)
FR (1) FR2629825B1 (instruction)
GB (1) GB2218102B (instruction)
IE (1) IE930109L (instruction)
IL (1) IL89881A (instruction)
IT (1) IT1235894B (instruction)
LU (1) LU87495A1 (instruction)
MY (1) MY108554A (instruction)
NL (1) NL8900864A (instruction)
NZ (1) NZ228677A (instruction)
SE (1) SE8901241L (instruction)
WO (1) WO1989009786A1 (instruction)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DK0477499T3 (da) * 1990-08-04 1994-05-30 Hoechst Ag Gonadoliberin-antagonister
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
AU672595B2 (en) * 1992-02-13 1996-10-10 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
SG50426A1 (en) * 1993-05-20 1998-07-20 Biotech Australia Pty Ltd Lhrh antagonists
DE69434181T2 (de) * 1993-08-09 2005-12-01 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Therapeutische Peptidderivate
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
ES2285735T3 (es) 1996-07-25 2007-11-16 Biogen Idec Inc Modelo molecular para inhibidores de vla-4.
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
EP1053001B1 (en) * 1998-02-13 2010-12-15 Amylin Pharmaceuticals, Inc. Novel mixed amylin activity compounds
KR100636713B1 (ko) 1998-05-28 2006-10-20 바이오겐 아이덱 엠에이 인코포레이티드 신규의 ＶＬＡ－４ 억제제: ｏＭｅＰＵＰＡ－Ｖ
UA75581C2 (en) 1999-08-13 2006-05-15 Biogen Inc Cell adhesion inhibitor
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
AU2009303389B2 (en) 2008-10-17 2014-10-16 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives

Also Published As

Publication number Publication date
NZ228677A (en) 1994-08-26
NL8900864A (nl) 1989-11-01
AU3263789A (en) 1989-10-12
SE8901241D0 (sv) 1989-04-07
JPH01305099A (ja) 1989-12-08
IT8947823A0 (it) 1989-04-07
DK163689D0 (da) 1989-04-05
DK163689A (da) 1989-10-30
CH682152A5 (instruction) 1993-07-30
WO1989009786A1 (en) 1989-10-19
AU623385B2 (en) 1992-05-14
BE1004357A4 (fr) 1992-11-10
FR2629825A1 (fr) 1989-10-13
GB2218102B (en) 1992-09-16
AU3362889A (en) 1989-11-03
ATA900689A (de) 1997-01-15
LU87495A1 (fr) 1989-11-14
GB8907652D0 (en) 1989-05-17
FR2629825B1 (fr) 1993-05-14
IT1235894B (it) 1992-11-23
IE930109L (en) 1989-10-08
ES2015645A6 (es) 1990-09-01
IL89881A0 (en) 1989-12-15
GB2218102A (en) 1989-11-08
MY108554A (en) 1996-10-31
JPH0789994A (ja) 1995-04-04
IL89881A (en) 1994-05-30
US5541159A (en) 1996-07-30

Similar Documents

Publication Publication Date Title
SE8901241L (sv) Peptide derivatives
DE69432758D1 (en) Therapeutisch wirksame peptidderivate
SE8703938L (sv) Peptidderivat
MXPA97007050A (es) Derivados de hormona pepticida lipofilica.
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
CA2122717A1 (en) Hemoglobins as drug delivery agents
WO1990006949A3 (en) Peptide derivatives
FI101938B1 (fi) Polypeptidijohdannaisia
IT8223795A0 (it) Gamma), relativi veicoli di polipeptidi contenenti la sequenza espressione, loro procedimento di degli amminoacidi dell'interferone preparazione, composizioni umano immune (interferone umano farmaceutiche contenenti tali polipeptidi.
NO891711D0 (no) Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr.
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
FR2665951B1 (fr) Systeme de liaison cassable permettant de separer des pieces au moyen d'une charge detonante.
FR2382460A1 (fr) Complexe antigene proteine pour bloquer les reactions allergiques
ATE202708T1 (de) Peptidantagonisten des bradykinin
BG104539A (en) Ifnar-2/ifn complex
Bruck et al. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
DE68909584D1 (de) Irreversible peptidliganden fuer bombesinrezeptoren.
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
EP0372503A3 (en) Anticoagulant peptides
DK0548177T3 (da) 5-Aminosalicylsyrederivater til terapi af kroniske inflammatoriske tarmsygdomme
DE69829953D1 (de) Kristallisation von proteinen
GB1179787A (en) Stabilised and Potentiated Therapeutic Enzyme Compositions
FR2608398B1 (fr) Perfectionnements au systeme de fixation d'etageres d'angles par tasseaux et rainures
Halpem Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factoras therapeutic

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901241-3